Cargando…
Voluntary warnings and the limits of good prescribing behavior: the case for de-adoption of meperidine
BACKGROUND: Meperidine (pethidine) offers little to no therapeutic advantage over other opioids, may be more prone to abuse, and produces a neurotoxic metabolite with a long half-life. The Institute for Safe Medication Practices (ISMP) issued warnings in 2004 and 2005 suggesting that meperidine be a...
Autores principales: | Friesen, Kevin J, Falk, Jamie, Bugden, Shawn |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4687958/ https://www.ncbi.nlm.nih.gov/pubmed/26719721 http://dx.doi.org/10.2147/JPR.S96625 |
Ejemplares similares
-
The safety of meperidine prescribing in older adults: A longitudinal population-based study
por: Friesen, Kevin J., et al.
Publicado: (2016) -
The effectiveness and limitations of regulatory warnings for the safe prescribing of citalopram
por: Friesen, Kevin J, et al.
Publicado: (2015) -
Cost of shingles: population based burden of disease analysis of herpes zoster and postherpetic neuralgia
por: Friesen, Kevin J., et al.
Publicado: (2017) -
Price of pain: population-based cohort burden of disease analysis of medication cost of herpes zoster and postherpetic neuralgia
por: Friesen, Kevin J, et al.
Publicado: (2016) -
The changing landscape of antiviral treatment of herpes zoster: a 17-year population-based cohort study
por: Friesen, Kevin J, et al.
Publicado: (2016)